Mode
Text Size
Log in / Sign up

Observational study examines syndemic conditions and condomless anal intercourse in transgender women

Observational study examines syndemic conditions and condomless anal intercourse in transgender wome…
Photo by Reproductive Health Supplies Coalition / Unsplash
Key Takeaway
Note: Observational surveillance data on syndemic conditions and sexual behavior lacks reported results.

An observational surveillance report investigated the relationship between structural and psychosocial syndemic conditions and condomless anal intercourse among Black, White, and Hispanic transgender women. The study was conducted across seven urban areas in the United States. The specific sample size, follow-up duration, and comparator group were not reported.

No main results were reported for the primary outcome of condomless anal intercourse. The report did not provide outcome measures, effect sizes, absolute numbers, p-values, confidence intervals, or direction of association. Secondary outcomes, safety data, and tolerability information were also not reported.

Key limitations include the observational study design, which cannot establish causality between syndemic conditions and sexual behavior. The findings may not be generalizable beyond the seven urban areas studied. Funding sources and potential conflicts of interest were not disclosed.

This surveillance report identifies an area for further investigation but provides no quantitative evidence to guide clinical practice. The absence of reported results prevents any assessment of the strength or nature of the observed associations. Clinicians should recognize this as preliminary surveillance data requiring confirmation through more rigorous research.

Study Details

EvidenceLevel 5
PublishedJan 2024
View Original Abstract ↓
This report examines the relationship between structural and psychosocial syndemic conditions and condomless anal intercourse among Black, White, and Hispanic transgender women from seven urban areas in the U.S.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.